Home › Funds › MPM BioImpact LLC › PVLA

MPM BioImpact LLC position in PVLA

PALVELLA THERAPEUTICS INC NEW COM · Health Care

MPM BioImpact LLC reported holding 204,027 shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM) in its Q2 2026 13F filing — a position valued at US$31.2M, representing 1.90% of its reported portfolio and ranking #20 among its reported holdings. MPM BioImpact LLC has disclosed PVLA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)204.03K sh
Reported value held$31.18M
Portfolio Weight1.90%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's PVLA position evolved

MPM BioImpact LLC first disclosed a stake in PVLA in Q3 2025 at 67,423 shares (US$4.2M). The position peaked in Q2 2026 at 204,027 shares, worth US$31.2M. Across 4 filings, MPM BioImpact LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 204,027 shares valued at US$31.2M — a reduction of -2,377 shares quarter over quarter.. Notable position changes include a 205% increase in Q4 2025 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 67.42K $4.23M New
Q4 2025 205.75K $21.54M Add
Q1 2026 206.40K $25.73M Hold
Q2 2026 204.03K $31.18M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NEW COM) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has MPM BioImpact LLC held PVLA?

MPM BioImpact LLC has disclosed PVLA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is MPM BioImpact LLC's current position in PVLA?

As of Q2 2026, MPM BioImpact LLC holds 204.03K shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM), valued at $31.18M, representing 1.90% of its reported portfolio and ranking #20.

Has MPM BioImpact LLC been buying or selling PVLA?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in PVLA. The position peaked in Q2 2026 at 204.03K shares.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 90 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.